64.49
Finanzdaten der Ptc Therapeutics Inc-Aktie (PTCT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
21.96%
164.68
|
211.01 | 178.88 | 1,176.10 | 196.79 |
|
|
13.48%
236.03
|
207.99 | 213.83 | 205.87 | 251.30 |
| Benefits Costs and Expenses |
29.77%
303.76
|
234.08 | 249.93 | 246.27 | 294.78 |
| Costs And Expenses |
29.77%
303.76
|
234.08 | 249.93 | 246.27 | 294.78 |
| Operating Income/Loss |
2,466%
-71.35
|
3.016 | -34.96 | 970.23 | -54.51 |
| Income/Loss From Continuing Operations Before Tax |
502.77%
-139.08
|
-23.07 | -71.05 | 929.83 | -97.99 |
| Income Tax Expense/Benefit, Deferred |
0.001
|
- | - | 0.002 | -0.003 |
| Income Tax Expense/Benefit |
89.43%
-4.118
|
-38.97 | -6.203 | 63.27 | 8.663 |
| Income/Loss From Continuing Operations After Tax |
949.05%
-134.97
|
15.90 | -64.85 | 866.56 | -106.65 |
|
|
949.05%
-134.97
|
15.90 | -64.85 | 866.56 | -106.65 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
98.86%
0.8918
|
78.47 | 78.15 | 78.12 | 76.93 |
| Diluted Average Shares |
98.38%
1.4118
|
87.12 | 78.15 | 86.39 | 76.93 |
| Basic Earnings Per Share |
1,010%
-1.82
|
0.20 | -0.83 | 11.09 | -1.39 |
| Diluted Earnings Per Share |
935.00%
-1.67
|
0.20 | -0.83 | 10.04 | -1.39 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):